Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds
Sign Up to like & getrecommendations! Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.2c04769
Abstract: Janus kinases (JAKs) are involved in a wide variety of cell signaling associated with T-cell and B-cell mediated diseases. The pathogenesis of common lymphoid-derived diseases and leukemia cancer has been implicated in JAK2 and JAK3.… read more here.
Keywords: cell; discovery jak2; jak2 inhibitors; inhibitors quinoxalinone ... See more keywords